Search results
Nabla Bio secures $26m in Series A funding round
Pharmaceutical Technology via Yahoo Finance· 2 days agoUS pharmaceutical company Nabla Bio has secured $26m for generative protein design in a Series A financing round led by Radical Ventures. The round...
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Clinical Trials Arena via Yahoo Finance· 3 weeks agoUS-based Cerevance has secured $47m in Series B-1 extension funding to finance the upcoming Phase...
AbbVie, Sosei Build In 2020 Pact With New Neurological Disease-Focused Agreement
Benzinga via Yahoo Finance· 2 years agoSosei Group Corporation and AbbVie Inc (NYSE: ABBV) announced a new drug discovery collaboration and...
Artelo's (ARTL) FABP5 Inhibitor Effective in Pre-Clinical Study
Zacks via Yahoo Finance· 2 years agoArtelo Biosciencs ARTL were up 46% on Aug 16, during market hours, after the company announced...
FATE To End Janssen Deal and Prioritize Pipeline Development
Zacks via Yahoo Finance· 1 year agoFate Therapeutics, Inc. FATE announced that it has declined a proposal from Janssen Biotech, Inc., a...
Q1 2024 Predictive Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 20 hours agoParticipants Glenn Garmont; Investor Relations; LifeSci Venture Partners LP Raymond Vennare; Chairman of the Board, Chief Executive Officer; Predictive Oncology Inc Josh Blacher; Interim Chief ...
This New Oral Fertility Drug Would Offer Needle-Free IVF — Here's What to Know
SheKnows via Yahoo News· 11 months agoOn average, women undergoing in vitro fertilization (IVF) have up to 60 shots across two treatment...
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
Zacks via Yahoo Finance· 3 weeks agoIt was a busy week in the biotech sector with earnings reports from bigwigs Biogen BIIB and Bristol...
FMR LLC Adjusts Stake in Longboard Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 6 months agoOverview of FMR LLC (Trades, Portfolio)'s Recent Stock Transaction On October 31, 2023, FMR LLC...
OKYO Pharma Files US IND Application For Dry Eye Disease Candidate
Benzinga via Yahoo Finance· 1 year agoOKYO Pharma Limited (NASDAQ: OKYO) filed an Investigational New Drug (IND) application with the FDA...
